Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 62Rectal Neoplasms 49Breast Neoplasms 48Stomach Neoplasms 37Esophageal Neoplasms 36Colorectal Neoplasms 33Lung Neoplasms 30Squamous Cell Carcinoma of Head and Neck 28Pancreatic Neoplasms 25Brain Neoplasms 25Glioblastoma 23Neoplasms 22Sarcoma 21Neoplasm Metastasis 20Carcinoma, Hepatocellular 18Head and Neck Neoplasms 17Glioma 16Esophageal Squamous Cell Carcinoma 16Colonic Neoplasms 13Recurrence 11Ovarian Neoplasms 10Oropharyngeal Neoplasms 10Melanoma 10Astrocytoma 10Adenocarcinoma Of Esophagus 10Thyroid Neoplasms 9Hypopharyngeal Neoplasms 9Prostatic Neoplasms 8Laryngeal Neoplasms 8Central Nervous System Neoplasms 8

Interventions

pembrolizumab 4Nivolumab 3toripalimab 2sintilimab 2Neoadjuvant Therapy 2Celecoxib 2tislelizumab 1spartalizumab 1relatlimab 1regorafenib 1fludarabine phosphate 1fludarabine 1durvalumab 1denileukin diftitox 1danvatirsen 1camrelizumab 1avelumab 1atezolizumab 1XELOX 1Taxes 1Surgical Procedures, Operative 1Radiation Dose Hypofractionation 1Paclitaxel 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Ipilimumab 1Induction Chemotherapy 1Immunotherapy 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Turcot syndrome × Surgical Procedures, Operative × Clear all
NCT06646445 2025-06-13

PREMICES

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡